【Area 1】
K23-1050 Structural basis of ribosome associated quality control
K24-1114 Uncovering human neural differentiation by advanced multi-omics for the regeneration of
brain function
K24-1115 The study of primed-umbilical cord-derived mesenchymal stromal cells to
improve immunosuppressive properties in the treatemnet of GVHD
K24-1116 Deciphering and targeting EZH2 non-canonical activities to overcome therapy resistance in
acute myeloid leukemia.
K24-1117 Functional interplay between endogenous MLL1/KMT2A and MLL-fusion oncoproteins
K24-1118 Structures of the Gcn2 kinase on the ribosome
K25-1168 Mechanisms of Action of Mesenchymal Stromal Cell Therapy in Newborn Rats from
Pregnant Rats with Intrauterine "Augmented Inflammation"
K25-1185 The development of acral melanoma model and a novel early diagnostic method based on
stem cell dynamics
【Area 2】
K23-2090 Genome stability and DNA methylation
K24-2120 Exploration of the functional role of FOXP1 in the development of secondary myelofibrosis
K24-2121 Cell Technology for Testing Indonesian Natural Products as Anticancer and Antiaging Agents
K24-2122 Regulation of DNA methylation on the nucleosome
K25-2117 An integrated analysis of molecular genomic and metagenomic data in Asian colorectal
cancer through international collaboration
K25-2153 Structural basis of the DNA methylation maintenance
K25-2169 Regulatory mechanism of maintenance DNA methylation
K25-2170 Large-scale gene regulatory network estimation from single-cell transcriptome based on
high-performance computing
K25-2171 Deep learning-based approaches for non-coding variant effect prediction
K25-2172 Novel Treatment of AML by Combination of Chemotherapy and CD112-Targeted Immunotherapy
K25-2173 Establishing pre-clinical models to study functions of intellectual disability associated
caused by a variant in the synaptotagmin 4 (SYT4) gene
K25-2174 Tissue-engineered VivoSpheres for cancer modeling and drug screening
K25-2183 Humanizing the Rat Immune System: A Transformative Tool for Preclinical Cancer Research
K25-2184 Establishment of Humanized, Tumor Xenograft, and PDX Rat Model for Translational Research
K25-2187 Development and interrogation of novel blood cancer model systems
K25-2188 Investigation of drug molecular representation using advanced AI models and its application
in drug-target identification
【Area 3】
K24-3123 Immunopathology of, and Response to, Protozoan Parasites
K24-3124 Discovery of antibodies with potential therapeutic applications aided by machine learning
and artificial intelligence.
K25-3118 Development of a Universal Influenza Vaccine
K25-3119 A new vaccine strategy to combat RSV infection
K25-3120 Preparing for the next pandemic through international collaboration from Asia
K25-3146 Nanozymes for Tumor Catalytic Immunotherapy
K25-3159 Development of mucosal vaccines designed for infant based on the understanding of
the infantile nasopharyngeal and gut mucosal immune system
K25-3165 Harnessing CRISPR-Cas9 and DNA Repari Pathways (COMBI-CRISPR) for Temporally
Inducible IFNAR1 Mouse Models to Advance Vaccine Research for Severe Viral Diseases
K25-3167 Development of viral inhibitors targeting envelope proteins
K25-3175 Crossroads between inflammasomes and adaptive immune responses
K25-3190 Employing molecular and systems approaches for human vaccine and
immunotherapy development against cancer and infectious diseases